Rating Change
HC Wainwright & Co. reiterated its Buy rating on Envoy Medical, Inc. (NASDAQ:COCH) on November 09, 2026.
HC Wainwright & Co. reiterated its Buy rating on Envoy Medical, Inc.

At publication ·
Envoy Medical, Inc. (NASDAQ:COCH) · reiterate
At a glance
HC Wainwright & Co. reiterated its Buy rating on Envoy Medical, Inc. (NASDAQ:COCH) on November 09, 2026.
Envoy Medical, Inc. operates in the Healthcare sector. The stock currently trades at $7.29 with a market capitalization of $17.3M. The stock has gained 878.1% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Envoy Medical, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 09, 2026 | HC Wainwright & Co. | Buy | N/A |
| Oct 27, 2026 | Lake Street | Buy | N/A |
| Oct 06, 2026 | Lake Street | Buy | N/A |
| Aug 21, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 27, 2026 | LUCID CAPITAL MARKETS | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View COCH Stock Page
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Envoy Medical, Inc. (NASDAQ:COCH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the COCH forecast page.
Current market data
NASDAQ · COCH
$6.81
Down: -$0.14 · -2.01%
Live quote updated
Keep reading